Back to search
FDAFDA · Food and drugs·Recall number D-1107-2018

Valsartan Tablets USP 320 mg, 90-count, plastic child resistant bottle, Rx Only, Preferred Pharmaceuticals, Inc., 1250 N. Lakeview Ave., Suite O, Anaheim, CA 92807, NDC 68788-6882-9

Published August 29, 2018 · Recall initiated: August 15, 2018

Summary

FDA records drug Class II recall D-1107-2018, published August 29, 2018 and initiated August 15, 2018. Recalling firm: Preferred Pharmaceuticals, Inc; Status: Terminated; Reported quantity: 9 bottles consisting of 90 tables each bottle; Lot: Lot # G2017F NDC 68788-6882-9. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Preferred Pharmaceuticals, Inc
Distributor
Products were distributed to one distributor in Alabama who may have further distributed the product to the consumer level.
Lot
Lot # G2017F NDC 68788-6882-9
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Valsartan Tablets USP 320 mg, 90-count, plastic child resistant bottle, Rx Only, Preferred Pharmaceuticals, Inc., 1250 N. Lakeview Ave., Suite O, Anaheim, CA 92807, NDC 68788-6882-9 recalled?

Yes. FDA published recall D-1107-2018 on August 29, 2018. Reported hazard: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

What should I do if I have this product?

Voluntary: Firm initiated · Letter